PUMA and NOXA have demonstrated a predictive potential in several cancers such as in hepatocellular carcinoma [13,14] and gallbladder adenocarcinoma [15,16], although their value in PC has not been fully elucidated. This evidence concerns the gene PMAIP1 and hepatocellular carcinoma.